Pillstats
Rx only · Tablet, Film Coated · Oral

Pazopanib Hydrochloride

Brands: Votrient · Pazopanib · Pazopanib Hydrochloride

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)714438
US makers3 labelers
Packages5
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

941892833772025 Q12025 Q22025 Q32025 Q42026 Q1
247
Rx · 2026 Q1
23K
Units dispensed
-25%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Torrent Pharmaceuticals Limitedunknown3SUPPLYING
Novugen Pharma (USA) LLC.unknown1SUPPLYING
Novartis Pharmaceuticals Corporationunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Nov 20, 2023
    RECALLRecall (Class III): Votrient (pazopanib) 200 mg tablets, 120-count bottle, Rx Only, Manufactured by: Siegried Barbera, S.L., Barbera del Va…

    Failed Dissolution Specifications — Recalling firm: Siegfried Barbera, SL — Nationwide